六块爱理不理 8块高攀不起查看全文
格隆汇11月15日丨Aytu BioPharma(AYTU.US)盘前涨18.76%,报0.23美元。公司2023年Q1财报实现营收2765.5万美元,前值为2189.7万美元,预期值为2430万美元,超出市场预期13.81%;每股收益为-0.06美元,前值为-0.33美元,预期值为-0.18美元,超出市场预期66.67%。 网页链接
$Aytu BioPharma(AYTU)$ 8-K/A [Amend] Current report, item 9.01 Accession Number: 0001437749-21-013049 Act: 34 Size: 1 MB 网页链接
$Aytu BioPharma(AYTU)$ 8-K Current report, items 5.07 and 9.01 Accession Number: 0001437749-21-013051 Act: 34 Size: 36 KB 网页链接
$Aytu BioPharma(AYTU)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001437749-21-012928 Act: 34 Size: 43 KB 网页链接
$Aytu BioPharma(AYTU)$ 8-K Current report, item 1.02 Accession Number: 0001437749-21-012839 Act: 34 Size: 19 KB 网页链接
$Aytu BioPharma(AYTU)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001437749-21-012840 Act: 34 Size: 43 KB 网页链接
$Aytu BioPharma(AYTU)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001437749-21-012543 Act: 34 Size: 12 MB 网页链接
$Aytu BioPharma(AYTU)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001437749-21-012522 Act: 34 Size: 183 KB 网页链接
$Aytu BioPharma(AYTU)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000919574-21-003313 Size: 15 KB 网页链接
$Aytu BioPharma(AYTU)$ DEF 14A Other definitive proxy statements Accession Number: 0001437749-21-009173 Act: 34 Size: 400 KB 网页链接
$Aytu BioPharma(AYTU)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001437749-21-009171 Act: 33 Size: 119 KB 网页链接